W. C. Boon

458 total citations
11 papers, 364 citations indexed

About

W. C. Boon is a scholar working on Genetics, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, W. C. Boon has authored 11 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Molecular Biology. Recurrent topics in W. C. Boon's work include Estrogen and related hormone effects (5 papers), Hormonal Regulation and Hypertension (3 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). W. C. Boon is often cited by papers focused on Estrogen and related hormone effects (5 papers), Hormonal Regulation and Hypertension (3 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). W. C. Boon collaborates with scholars based in Australia, Singapore and United States. W. C. Boon's co-authors include Margaret E. E. Jones, E R Simpson, Rachel Hill, Marie Misso, K. Hewitt, Colin D. Clyne, Jiong Zhou, R. H. Rozendal, Kerry J. McInnes and John P. Coghlan and has published in prestigious journals such as PLoS ONE, Endocrine Reviews and Trends in Endocrinology and Metabolism.

In The Last Decade

W. C. Boon

11 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. C. Boon Australia 9 149 109 89 54 45 11 364
M Okamoto Japan 14 80 0.5× 104 1.0× 137 1.5× 65 1.2× 59 1.3× 32 541
Teng Zhao China 12 205 1.4× 90 0.8× 191 2.1× 68 1.3× 17 0.4× 29 493
Toshimitsu Okeda Japan 11 136 0.9× 123 1.1× 80 0.9× 94 1.7× 12 0.3× 24 511
Jess Hatfield United States 12 22 0.1× 69 0.6× 77 0.9× 60 1.1× 31 0.7× 27 308
Shinji Sawano Japan 11 69 0.5× 377 3.5× 88 1.0× 69 1.3× 9 0.2× 38 571
R. S. Perlstein United States 9 26 0.2× 178 1.6× 83 0.9× 36 0.7× 55 1.2× 11 564
John W. Leidy United States 11 44 0.3× 258 2.4× 94 1.1× 89 1.6× 10 0.2× 25 415
Lijun Yin China 13 42 0.3× 30 0.3× 190 2.1× 81 1.5× 18 0.4× 27 439
Doreen Zegers Belgium 14 129 0.9× 68 0.6× 226 2.5× 131 2.4× 33 0.7× 30 627
A. Berthold Germany 9 85 0.6× 61 0.6× 154 1.7× 138 2.6× 8 0.2× 15 439

Countries citing papers authored by W. C. Boon

Since Specialization
Citations

This map shows the geographic impact of W. C. Boon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. C. Boon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. C. Boon more than expected).

Fields of papers citing papers by W. C. Boon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. C. Boon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. C. Boon. The network helps show where W. C. Boon may publish in the future.

Co-authorship network of co-authors of W. C. Boon

This figure shows the co-authorship network connecting the top 25 collaborators of W. C. Boon. A scholar is included among the top collaborators of W. C. Boon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. C. Boon. W. C. Boon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Tomas, Doris, et al.. (2016). Restoration of the Dopamine Transporter through Cell Therapy Improves Dyskinesia in a Rat Model of Parkinson’s Disease. PLoS ONE. 11(4). e0153424–e0153424. 7 indexed citations
2.
Wilkins, Ella, Justin P. Rubio, Katya Kotschet, et al.. (2012). A DNA resequencing array for genes involved in Parkinson’s disease. Parkinsonism & Related Disorders. 18(4). 386–390. 9 indexed citations
3.
Hill, Rachel, et al.. (2008). Evidence for the existence of an estrogen-responsive sexually dimorphic group of cells in the medial preoptic area of the 129SvEv mouse strain. International Journal of Impotence Research. 20(3). 315–323. 8 indexed citations
4.
Jones, Margaret E. E., Kerry J. McInnes, W. C. Boon, & E R Simpson. (2007). Estrogen and adiposity—Utilizing models of aromatase deficiency to explore the relationship. The Journal of Steroid Biochemistry and Molecular Biology. 106(1-5). 3–7. 45 indexed citations
5.
Misso, Marie, K. Hewitt, W. C. Boon, et al.. (2005). Cholesterol Feeding Prevents Adiposity in the Obese Female Aromatase Knockout (ArKO) Mouse. Hormone and Metabolic Research. 37(1). 26–31. 10 indexed citations
6.
Simpson, E R, Marie Misso, K. Hewitt, et al.. (2005). Estrogen—the Good, the Bad, and the Unexpected. Endocrine Reviews. 26(3). 322–330. 204 indexed citations
7.
Simpson, E R, Stephen J. McPherson, Margaret E. E. Jones, et al.. (2004). Role of Estrogens in the Male Reproductive Tract. PubMed. 89–112. 2 indexed citations
8.
Moritz, Karen M., W. C. Boon, & E. Marelyn Wintour. (1999). Aldosterone secretion by the mid-gestation ovine fetus: role of the AT2 receptor. Molecular and Cellular Endocrinology. 157(1-2). 153–160. 13 indexed citations
9.
Boon, W. C., John P. Coghlan, Kathleen M. Curnow, & John G. McDougall. (1997). Aldosterone SecretionA Molecular Perspective. Trends in Endocrinology and Metabolism. 8(9). 346–354. 15 indexed citations
10.
Boon, W. C., Peter J. Roche, Aldona Butkus, et al.. (1997). Functional and expression analysis of ovine steroid 11ß-hydroxylase (Cytochrome P45011ß). Endocrine Research. 23(4). 325–347. 15 indexed citations
11.
Rozendal, R. H., et al.. (1972). Graphic representation of the relationship between oxygen-consumption and characteristics of normal gait of the human male.. PubMed. 75(4). 305–14. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026